Enhancing Adaptations to Exercise

Overview

About this study

Researchers are trying to understand how chronic inflammation affects muscle function and responses to exercise.They are also trying to determine if suppressing chronic inflammation using omega-3 fatty acids (n3-PUFA) restores skeletal muscle function and exercise responsiveness in older adults.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Men and women between the ages of 20-35 years
  • Men and women between the ages of 65-85 years

Exclusion Criteria:

  • Regular use of omega-3 nutritional supplements
  • Diabetes or fasting plasma glucose > or equal to 126 mg/dL
  • Anemia (female subjects hemoglobin of <11 g/dl and male subjects hemoglobin <12 g/dl)
  • Active coronary artery disease or history of unstable macrovascular disease (unstable angina, myocardial infarction, stroke, and revascularization of coronary, peripheral or carotid artery within 3 months of recruitment)
  • Renal failure (serum creatinine > 1.5mg/dl)
  • Chronic active liver disease (AST>144 IU/L or ALT>165 IU/L)
  • Oral warfarin group medications or history of blood clotting disorders.
  • international normalized ratio (INR) >2.01.5
  • Smoking
  • Pregnancy or breastfeeding
  • Alcohol consumption greater than 2 glasses/day or other substance abuse
  • Untreated or uncontrolled hypothyroidism
  • Debilitating chronic disease (at the discretion of the investigators)
  • Fish or shellfish allergy

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ian Lanza, Ph.D.

Closed for enrollment

Contact information:

Ian Lanza Ph.D.

(507) 255-8147

Lanza.Ian@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20342655

Mayo Clinic Footer